Pulmatrix Correlations
PULM Stock | USD 6.29 0.25 4.14% |
The current 90-days correlation between Pulmatrix and Crinetics Pharmaceuticals is -0.18 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pulmatrix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pulmatrix moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Pulmatrix Correlation With Market
Good diversification
The correlation between Pulmatrix and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and DJI in the same portfolio, assuming nothing else is changed.
Pulmatrix |
Moving together with Pulmatrix Stock
Moving against Pulmatrix Stock
0.83 | INZY | Inozyme Pharma | PairCorr |
0.81 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.78 | LLY | Eli Lilly Buyout Trend | PairCorr |
0.72 | ME | 23Andme Holding | PairCorr |
0.65 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.64 | VALN | Valneva SE ADR | PairCorr |
0.61 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.59 | GMAB | Genmab AS | PairCorr |
0.56 | A | Agilent Technologies Sell-off Trend | PairCorr |
0.56 | IPSC | Century Therapeutics Buyout Trend | PairCorr |
0.53 | LEGN | Legend Biotech Corp | PairCorr |
0.46 | EQ | Equillium | PairCorr |
0.34 | CINGW | Cingulate Warrants | PairCorr |
0.85 | AMGN | Amgen Inc | PairCorr |
0.84 | PHAT | Phathom Pharmaceuticals | PairCorr |
0.79 | ABBV | AbbVie Inc | PairCorr |
0.71 | SNDX | Syndax Pharmaceuticals | PairCorr |
0.7 | LYRA | Lyra Therapeutics | PairCorr |
0.65 | ALEC | Alector | PairCorr |
0.6 | NKTX | Nkarta Inc | PairCorr |
0.54 | PCVX | Vaxcyte | PairCorr |
0.45 | MDWD | Mediwound | PairCorr |
0.44 | MTEM | Molecular Templates | PairCorr |
0.41 | BGNE | BeiGene | PairCorr |
0.33 | ASMB | Assembly Biosciences | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Pulmatrix Stock performing well and Pulmatrix Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pulmatrix's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CAPR | 6.80 | 2.66 | 0.50 | 16.70 | 4.10 | 18.22 | 69.31 | |||
SLNO | 2.19 | 0.26 | 0.11 | 0.35 | 2.18 | 6.31 | 13.33 | |||
BPTH | 4.04 | (0.41) | 0.00 | 5.61 | 0.00 | 6.67 | 51.22 | |||
MBRX | 3.83 | 0.35 | 0.04 | (0.62) | 4.30 | 9.75 | 35.41 | |||
CRNX | 1.71 | (0.01) | (0.01) | 0.11 | 2.43 | 3.67 | 16.75 | |||
ASMB | 2.91 | 0.05 | 0.00 | 0.25 | 4.40 | 8.49 | 24.80 | |||
TIL | 9.31 | 1.37 | 0.24 | 0.39 | 6.84 | 20.63 | 105.83 | |||
CTMX | 2.68 | (0.45) | 0.00 | (0.24) | 0.00 | 5.36 | 20.61 | |||
ACHL | 2.03 | 0.47 | 0.20 | 0.45 | 1.55 | 3.06 | 38.16 |
Pulmatrix Corporate Management
MBA CMA | Interim Officer | Profile | |
Alexander Klibanov | Founder | Profile | |
Margaret MD | Chief Officer | Profile | |
David JD | Advisor | Profile | |
Aidan Curran | VP Affairs | Profile |